<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Maltais R</submitter><funding>Ministère de l&amp;apos;économie et de l&amp;apos;innovation du Québec</funding><pagination>11181</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8537847</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(20)</volume><pubmed_abstract>Aminosteroid derivative RM-581 was previously identified as an endoplasmic-reticulum (ER) stress inducer with potent in vitro and in vivo anticancer activities. We report its evaluation in androgen-independent prostate cancer (PC-3) cells. RM-581 efficiently blocks PC-3 cell proliferation with stronger activity than that of a selection of known antineoplastic agents. This later also showed a synergistic effect with docetaxel, able to block the proliferation of docetaxel-resistant PC-3 cells and, contrary to docetaxel, did not induce cell resistance. RM-581 induced an increase in the expression level of ER stress-related markers of apoptosis, potentially triggered by the presence of RM-581 in the ER of PC-3 cells. These in vitro results were then successfully translated in vivo in a PC-3 xe</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Induction of Endoplasmic Reticulum Stress-Mediated Apoptosis by Aminosteroid RM-581 Efficiently Blocks the Growth of PC-3 Cancer Cells and Tumors Resistant or Not to Docetaxel.</pubmed_title><pmcid>PMC8537847</pmcid><funding_grant_id>N/A</funding_grant_id><pubmed_authors>Roy J</pubmed_authors><pubmed_authors>Poirier D</pubmed_authors><pubmed_authors>Maltais R</pubmed_authors><pubmed_authors>Sato S</pubmed_authors><pubmed_authors>Perreault M</pubmed_authors><pubmed_authors>Levesque JC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Induction of Endoplasmic Reticulum Stress-Mediated Apoptosis by Aminosteroid RM-581 Efficiently Blocks the Growth of PC-3 Cancer Cells and Tumors Resistant or Not to Docetaxel.</name><description>Aminosteroid derivative RM-581 was previously identified as an endoplasmic-reticulum (ER) stress inducer with potent in vitro and in vivo anticancer activities. We report its evaluation in androgen-independent prostate cancer (PC-3) cells. RM-581 efficiently blocks PC-3 cell proliferation with stronger activity than that of a selection of known antineoplastic agents. This later also showed a synergistic effect with docetaxel, able to block the proliferation of docetaxel-resistant PC-3 cells and, contrary to docetaxel, did not induce cell resistance. RM-581 induced an increase in the expression level of ER stress-related markers of apoptosis, potentially triggered by the presence of RM-581 in the ER of PC-3 cells. These in vitro results were then successfully translated in vivo in a PC-3 xe</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2025-04-20T02:02:14.468Z</modification><creation>2025-04-20T02:02:14.468Z</creation></dates><accession>S-EPMC8537847</accession><cross_references><pubmed>34681843</pubmed><doi>10.3390/ijms222011181</doi></cross_references></HashMap>